Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
Ileana Piña MD, MPH, FAHA, FACC
Ileana L. Piña MD, MPH, FAHA, FACC Advisory Board
Joerg Herrmann MD
Joerg Herrmann MD Associate Editor
See All Experts
featured
Published in Cardiology

Journal Scan / Research · January 15, 2014

RIBS V: Drug-Eluting Balloon vs Everolimus-Eluting Stent in Patients With BMS In-Stent Restenosis

Journal of the American College of Cardiology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI

Jason Garlie MD

Journal of the American College of Cardiology
A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal Stent In-Stent Restenosis: The RIBS V Clinical Trial
J Am Coll Cardiol 2014 Jan 08;[EPub Ahead of Print], F Alfonso, MJ Pérez-Vizcayno, A Cárdenas, B García del Blanco, B Seidelberger, A Iñiguez, M Gómez-Recio, M Masotti, MT Velázquez, J Sanchís, A García-Touchard, J Zueco, A Bethencourt, R Melgares, A Cequier, A Dominguez, V Mainar, JR López-Mínguez, J Moreu, V Martí, R Moreno, P Jiménez-Quevedo, N Gonzalo, C Fernández, C Macaya

Further Reading

Most Read This Week

Recently Updated